-
Signature
-
/s/ Jeffrey W. Ubben
-
Stock symbol
-
EVA
-
Transactions as of
-
Apr 26, 2023
-
Transactions value $
-
$0
-
Form type
-
4
-
Date filed
-
4/27/2023, 07:27 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
EVA |
Common Stock |
Award |
$0 |
+1.53K |
+19.03% |
$0.00 |
9.54K |
Apr 26, 2023 |
Direct |
F1, F2 |
holding |
EVA |
Common Stock |
|
|
|
|
|
5.74M |
Apr 26, 2023 |
See footnotes |
F1, F3 |
holding |
EVA |
Series A Preferred Stock, par value $0.001 per share |
|
|
|
|
|
1.86M |
Apr 26, 2023 |
See footnotes |
F1, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
In-Cap may be deemed to be a director by deputization for purposes of Section 16 under the Securities Exchange Act of 1934, as amended, by virtue of the fact that the Reporting Person currently serves on the board of directors of the Issuer. Eva Zlotnicka, a Founder and Managing Partner at In-Cap, also serves on the board of directors of the Issuer. Ms. Zlotnicka has separately filed a Form 4 to report an award which she holds for the benefit of In-Cap and the In-Cap Funds.